Mitigation Strategies for Raw Materials Supply Chain Challenges in Biologics Manufacturing

Introduction Supply chain constraints related to the COVID-19 pandemic presented unprecedented challenges to pharmaceutical manufacturers. At Biogen, hundreds of unique raw materials are used to produce dozens of commercial and clinical drug products across the global manufacturing network. Included...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy